Related references
Note: Only part of the references are listed.Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis
Ryutaro Kuraji et al.
PERIODONTOLOGY 2000 (2021)
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug -induced toxicity rather than autoimmune hepatitis
Hiroko Kimura et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review
Miguel Eugenio Zoubek et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran
Fariborz Mansour-Ghanaei et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
Viviana Nociti et al.
BRAIN AND BEHAVIOR (2018)
Pharmacodynamics and Tolerability of Repository Corticotropin Injection in Healthy Human Subjects: A Comparison With Intravenous Methylprednisolone
Ritu Lal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
Hiroyuki Eguchi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Naga P. Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Treatment of Acute Relapses in Multiple Sclerosis
Regina Berkovich
NEUROTHERAPEUTICS (2013)
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity
P. Carrier et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse
Memed Acar et al.
EUROPEAN NEUROLOGY (2012)
Corticosteroids for treating optic neuritis
Robin L. Gal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease
Anna Loraschi et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Pulsed methylpresnisolone revealed autoimmune hepatitis in a patient with multiple sclerosis
N. Maamouri et al.
JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE (2009)
Corticosteroid-induced adverse events in adults - Frequency, screening and prevention
Laurence Fardet et al.
DRUG SAFETY (2007)
Effect of relapses on development of residual deficit in multiple sclerosis
FD Lublin et al.
NEUROLOGY (2003)
Share Paper
